Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet. GSK plans to start ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Puff adds a dramatic look and gives a retro vibe when you pair the saree with it. Check out these stunning cotton saree puff blouse designs for every occasion. Cotton sarees are perfect for every ...

Subscribe to our FREE Newsletter, or Telegram and WhatsApp channels for the latest stories and updates. Despite efforts to curb cigarette use, 20% of Malaysians still reach for a pack, a stark ...

Also Read | Despite a 134% jump in last 1 year, Elara has a sell call on this defense stock HUL finalized its merger with GlaxoSmithKline Consumer Healthcare Limited (GSKCH) in 2020, after ...

The tax demand arises from the company's non-deduction of Tax Deducted at Source (TDS) related to a remittance of Rs 3,045 crore made for the acquisition of India Health Food Drink's (HFD) ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last ...

Take this as a sign — now's your chance to snag the always-sold-out Uggs you've been eyeing or the iconic Super Puff jacket. Aritzia just restocked The Super Puff line for 2024, and we predict these ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

The stock of pharma major GlaxoSmithKline Pharmaceuticals (GSK Pharma) was up about 5.7 per cent to Rs 3,059, taking the gains since its results earlier this month to 11 per cent. It has been a major ...